MedTrace Logo

The Combined Usage of Clinical Physical Finding in Management of COVID 19 Patients

NCT06528119 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2024-08-01

No results posted yet for this study

Summary

Physiological indicators such as blood pressure, heart rate, respiratory rate, and consciousness status of COVID-19 patients are used to apply the START (simple triage and rapid treatment, START), Modified Early Warning Score (MEWS), and quick Sequential Organ Failure Assessment (qSOFA) as tools for assessing clinical symptom tracking, deterioration, and subsequent improvement in COVID-19 patients. In response to the need for scarce manpower when a large number of emergency patients appear, a simple and easy-to-operate assessment method is adopted for mild patients, and artificial intelligence technology can be further used to assist in the assessment for early response and medication.

Conditions

  • COVID-19 Pandemic

Interventions

OTHER

COVID 19 pandemic

Physiological indicators such as blood pressure, heart rate, respiratory rate, and consciousness status of COVID-19 patients are used to apply the START, MEWS, and qSOFA in COVID-19 patients.(COVID 19 病患).

Sponsors & Collaborators

  • St. Martin De Porress Hospital

    lead OTHER

Principal Investigators

  • Chia-Hsi Chen, MD · St. Martin De Porres Hospital,emergency medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-30
Primary Completion
2022-05-01
Completion
2024-07-20

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06528119 on ClinicalTrials.gov